Tumor necrosis factor receptor-1 (TNFR1, CD120a) has been implicated in the pathogenesis of several experimental models of T cell-mediated autoimmune disorders, but its role in antibodymediated autoimmune diseases has not been addressed. 
Introduction
Tumor necrosis factor (TNF)-α and lymphotoxin-α are key TNF-α has been implicated in the development of MG. MG patients showed increased numbers of TNF-α mRNA mediators of inflammatory and autoimmune diseases by engagement of two distinct receptors, TNFR1 and TNFR2 expressing cells among blood mononuclear cells (MNC) compared to healthy subjects (9). In addition, spontaneous (1,2). TNFR1, the major mediator of TNF, has been implicated in the pathogenesis of T cell-mediated experimental autoproduction of TNF-α in blood MNC cultures has been demonstrated to be associated with disease severity (10). TNF-α immune models including encephalomyelitis (3,4), diabetes mellitus (5,6) and collagen-induced arthritis (7).
binding capacity of CD4 ϩ T cells has been demonstrated to be increased in MG patients compared with healthy subjects Experimental autoimmune myasthenia gravis (EAMG) is an antibody-mediated T cell-dependent animal model for (11) . Linomide, a synthetic compound that inhibits systemic TNF-α production, suppressed clinical EAMG in Lewis rats myasthenia gravis (MG) in humans. In MG and EAMG, autoantibodies against nicotinic acetylcholine receptor (12) . Early detection of TNF-α in muscle sections also implies its importance in EAMG (13) . However, the role of the TNF/ (AChR) of the neuromuscular junction are responsible for the functional loss of AChR and impaired muscle contraction (8).
TNFR pathway in MG and EAMG remains to be clarified.
To determine the role of TNFR1 in the development of a B Abingdon, UK) was incorporated in the emulsion at the first immunization according to a previous report (20) . cell-mediated autoimmune disease, we studied EAMG in TNFR1 -/-mice. Our results clearly demonstrate that TNFR1 -/-Mononuclear cell (MNC) suspensions mice do not develop MG after repeated immunization. Furthermore, the results suggest that addition of IL-12 at the stage Mice were immunized with 20 µg Torpedo AChR in CFA s.c. in the hind footpads and thighs and killed 7 days post primary of initial priming promotes the development of EAMG in the absence of a functional TNF/TNFR1 system. immunization (p.i.). MNC suspensions from the popliteal and inguinal lymph nodes (PILN) or spleen were prepared by grinding through a wire mesh. Erythrocytes in spleen cell suspension were osmotically lyzed. Cells were washed 3 times Methods in DMEM (Gibco, Paisley, UK) supplemented with 1% (v/v) Mice MEM (Gibco), 2 mM glutamine (Flow, Irvine, UK), 50 IU/ml penicillin and 50 µg/ml streptomycin (Gibco), and 10% TNFR1 -/-mice were generated by gene targeting in embryonic (v/v) FCS (Gibco). The cells were then adjusted to 2ϫ10 6 /ml. stem cells and have been previously described (14, 15 Arlington Heights, IL). Cells were harvested onto glass fiber Torpedo AChR was purified from the electric organs of filters and thymidine incorporation was measured. The results Torpedo californica (Pacific Biomarine, Venice, CA) by affinity were expressed as c.p.m. chromatography on a α-cobrotoxin-agarose resin (Sigma, St Louis, MO) as described previously (16) . The isolated product
Cytokine ELISA was pure as judged by SDS-PAGE. The purified AChR was Lymphoid cells from either PILN or spleen were cultured in used to induce EAMG and for stimulation of in vitro cultures.
the presence or absence of AChR or α146-162 for 48 h. Keyhole limpet hemocyanin (KLH) and concanavalin A (Con Supernatants were harvested and assessed for IFN-γ, IL-2 A) were purchased from Sigma. Myelin basic protein (MBP) and IL-4 using optEIA kits (PharMingen, San Diego, CA). to be used as control antigen was purified from normal mouse IL-10 was measured with an ELISA kit according to the brains (17) . The AChR α chain immunodominant peptide manufacturer's instruction (R & D Systems). IL-12 was meas-α146-162 (L-G-I-W-T-Y-D-G-T-K-V-S-I-S-P-E-S) was syntheured with an ELISA kit from Endogen (St Woburn, MA). sized and used for in vitro culture. An unrelated peptide (K-
Assays of anti-AChR IgG antibodies synthesized as control (18) . Purified protein derivative (PPD)
To enumerate anti-AChR IgG antibody-secreting cells among (Statens Seruminstitute, Copenhagen, Denmark) was used PILN MNC, solid-phase ELISPOT assays were used with as internal control. some modifications (21) . Briefly, wells of microtiter plates with nitrocellulose bottoms were coated with 100 µl of AChR or Induction and clinical evaluation of EAMG the control antigen MBP (10 µg/ml in PBS). Aliquots of 100 µl suspension containing 2ϫ10 5 MNC were added to individual Mice were immunized s.c. with 20 µg Torpedo AChR in complete Freund's adjuvant (CFA) in a total volume of 100 µl, wells in triplicate. After incubation for 24 h, the wells were emptied, followed by addition of rabbit anti-hamster IgG along the shoulders and back. Mice were boosted twice at 1 month interval with 20 µg of AChR in CFA at four sites on the (Sigma), biotinylated swine anti-rabbit IgG (Dakopatts, Copenhagan, Denmark) and avidin-biotin peroxidase complex shoulders and thighs. The mice were observed every other day in a blinded fashion for signs of muscle weakness (ABC; Dakopatts). After peroxidase staining, the red/brown immunospots corresponding to cells that had secreted anticharacteristic of EAMG. The disease symptoms were graded between 0 and 3 (19): 0, no definite muscle weakness; 1ϩ, AChR IgG were counted and standardized to numbers per 10 5 MNC. normal strength at rest but weak with chin on the floor and inability to raise the head after exercise consisting of 20 Isotypes of anti-AChR IgG antibodies were detected as described (22) . Microtiter plates (Costar, Corning, NY) were consecutive paw grips; 2ϩ, as grade 1ϩ and weakness at rest; and 3ϩ, moribund, dehydrated and paralyzed. Clinical coated with 100 µl/well of AChR (2 µg/ml) at 4°C overnight. Uncoated sites were blocked with 10% FCS (Gibco). Sera EAMG was confirmed by injection of neostigmine bromide and atropine sulfate (19) . In some experiments, 0.1 or 1 (diluted 1:200 for IgG2a, and 1:1000 for IgG1, IgG2b and IgG) with a predetermined amount of anti-AChR antibodies µg of recombinant mouse IL-12 (rmIL-12; R & D Systems, was added and incubated for 2 h at room temperature. Then, absence of TNFR1 alters the generation of AChR and immunodominant peptide α146-162-specific T cell responses, plates were incubated for 2 h with biotinylated rabbit antimouse IgG1, IgG2a or IgG2b (Cymbus Biotechnology, Hants, lymphoid cells from either PILN or spleen derived from TNFR1 -/-and wild-type mice 7 days p.i. with AChR were re-UK), followed by alkaline phosphatase-conjugated avidinbiotin complex (Dakopatts). The color was developed with stimulated in vitro with antigens. Lymphoid cells from TNFR1 -/-mice showed reduced proliferation, and produced reduced p-nitrophenyl phosphate and expressed as optical density (OD) at 405 nm. IgG2b:IgG1 ratios were calculated based amounts of IL-2 in response to AChR and α146-162 compared to wild-type mice ( Fig. 1A and B). In contrast, proliferative on OD readings at 1:1000 dilution of sera.
responses to either control Ku peptide, internal control PPD Determination of the antibody responses to KLH or Con A did not differ between two groups. To address whether the reduction in proliferation observed in AChRMice were primed with 100 µg of KLH in CFA on day 0 and boosted on day 15 p.i. Sera taken at day 30 p.i. were examined immunized TNFR1 -/-mice could be due to T cell anergy, T cell proliferation was determined after stimulation with AChR for anti-KLH IgG and isotype antibodies as described (23) . The results were expressed as OD values.
in the presence of IL-2. IL-2 supplementation to in vitro cultures did not restore the proliferative responses in TNFR1 -/-Statistical analysis mice as compared to wild-type mice (Fig. 1C) , excluding clonal anergy as an explanation for the inability of the T cells Differences between groups were analyzed by two-tailed Student's t-test. Clinical scores were analyzed using the nonto proliferate. In MG and EAMG, production of anti-AChR antibodies parametric Mann-Whitney U-test. Differences between the groups with respect to disease incidence were analyzed by depends on T cell help (25) . T cells differentiate into distinct T h cell subsets that produce characteristic cytokine profiles Fisher's exact test. The level of significance was set at P ϭ 0.05. upon activation (26) . To assess the cytokine profiles in the absence of TNFR1, supernatants were collected from AChRor α146-162-stimulated cell cultures obtained from TNFR1 -/-Results and wild-type mice, and analyzed for cytokine concentrations by ELISA. As shown in Fig. 2 Fig. 3A and B) , suggesting the generation of a polarized T h 2 response and induction of a resistant phenotype. This is TNF-α stimulates T cell proliferation through the IL-2/IL-2R pathway by up-regulating IL-2Rα (24) . To evaluate whether in accordance with previous findings that mice resistant to EAMG or tolerized by a recombinant fragment of human AChR α subunit produced predominantly T h 2 cytokines and IgG1 antibodies (27, 28) . ELISPOT assays confirmed decreased anti-AChR IgG production by TNFR1 -/-mice at the single-cell level (Fig. 3C ).
TNFR1 gene deficiency does not impair T cell proliferation in response to KLH and anti-KLH antibody response
To compare immune responses to AChR with those to other T cell-dependent antigens, mice were immunized with KLH plus CFA (see Methods) and sacrificed on day 7 p.i. Surprisingly, T cells from TNFR1 -/-and wild-type mice proliferated to a similar extent in response to KLH (Fig. 4A) . Accordingly, both TNFR1 -/-and wild-type mice mounted significant amounts of anti-KLH IgG antibodies. However, among the IgG isotypes, IgG2b antibodies were decreased in TNFR1 -/-mice compared with wild-type mice, confirming an association between TNFR1 and IgG2b responses (Fig. 4B) .
Co-injection of rmIL-12 with AChR in CFA restores T cell responses to AChR and sensitivity to EAMG in TNFR1 -/-mice
IL-12 is an obligatory factor for T h 1 cell generation and involved in the induction of EAMG in B6 mice (20) . As shown in Fig. 2 , secretion of IL-12 by lymphoid cells in TNFR1 -/-mice was diminished by 95% of that secreted by wild- with 0.1 µg of IL-12 and four of six TNFR1 -/-mice treated with 1 µg of IL-12 died of severe EAMG after the second humoral responses, and did not develop clinical EAMG. T cell proliferation and T h 1 cell responses against whole AChR boost (Table 2) . Surviving mice remained moribund until termination of the experiment (data not shown). The difference or its immunodominant α146-162 sequence were lower in TNFR1 -/-compared to wild-type mice, whereas levels of IL-4 in the mortality between TNFR1 -/-mice treated with IL-12 and those treated with PBS were associated with dramatically and IL-10 were concomitantly increased. Co-injection of rmIL-12 in TNFR1 -/-mice restored T cell responses to AChR and enhanced levels of anti-AChR antibodies and reduced levels of anti-AChR IgG1:IgG2b ratios (Table 2) . susceptibility to EAMG. The results directly demonstrate that TNFR1 regulates the development of EAMG and that IL-12 To further investigate the effect of IL-12, MNC derived from AChR-immunized TNFR1 -/-mice were propagated after in vitro may play a critical role in this process. The TNFR1 mediates many of the pleiotropic effects of supplementation with IL-12. Addition of IL-12 reversed the suppression of T cell proliferation and IFN-γ production in TNF-α in host defense and autoimmunity (1,2). Transgenic mice expressing human TNF transgenes developed spontan-TNFR1 -/-mice, suggesting that the decrease in IL-12 content in cultures was responsible for the decrease in proliferation eous inflammatory arthritis (29) . Non-obese diabetic (NOD) mice expressing soluble TNFR1 were protected from spontanand IFN-γ production ( Fig. 5A and B) . Therefore, the conversion of resistance to a state of high susceptibility by addition eous or accelerated insulin-dependent diabetes mellitus (5).
A clear beneficial role of anti-TNF therapy has been docuof IL-12 indicates that IL-12 is essential in deviating immune responses and disease phenotype in TNFR1 -/-mice. mented in established human rheumatoid arthritis and chronic inflammatory bowel disease (30, 31) . Paradoxically, chronic administration of TNF-α suppressed the function of mature T Discussion cells by altering TCR signaling in adult animals (32) . TNF-α injections have either positive or negative effect on the In the present study, we investigated the role of TNFR1 in the pathogenesis of EAMG in mice genetically deprived of TNFR1.
progression to diabetes in NOD mice depending on the age when administered. This discrepancy may reflect differences TNFR1 -/-mice mounted only low AChR-specific T h 1 and a TNFR1 -/-and wild-type mice were injected with either PBS, 0.1 µg of IL-12 or 1 µg of IL-12 emulsified in AChR ϩ CFA on day 0, followed by two boost immunizations with AChR ϩ CFA only, and monitored for muscular weakness characteristic of EAMG for 15 weeks p.i. Sera taken from TNFR1 -/-and wild-type mice at day 45 p.i. were subjected to ELISA. Levels of anti-AChR IgG, IgG1 and IgG2b antibodies were expressed as optimal density at 405 nm.
b Mean values Ϯ SD.
in involvement of local versus systemic immune responses, pathogenesis of this disease. Predictably, this phenomenon provides a therapeutic potential of anti-TNF-α therapy for MG duration of cytokine exposure and effector cells involved (33). Our results suggest that altered T h 1/T h 2 cytokine profiles, patients. However, the absence of TNFR1 can be compensated by addition of IL-12. This scenario provides plausible probably due to reciprocal regulation between T h 1 and T h 2 subsets, resulted in the resistance to EAMG in TNFR1 -/-mice. mechanisms of counteraction of various cytokine pathways in MG. TNFR1-related signaling is not essential for lymphoid organ genesis but rather for the cellular and structural organization of B cell follicles in all secondary lymphoid tissues (34). We Acknowledgements cannot exclude that altered formation of B cell follicles in TNFR1 -/-mice may influence antibody production, although differentiation of dendritic cells (35, 36) .
There is no general consensus on the phenotype (T h 1 or T h 2) of pathogenic T cells in EAMG. Studies from our laboratory and Abbreviations others showed that IFN-γ and IFN-γR were required for the AChR acetylcholine receptor development of EAMG (23, 27 
